{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T01:06:57Z","timestamp":1769735217103,"version":"3.49.0"},"reference-count":29,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T00:00:00Z","timestamp":1187827200000},"content-version":"vor","delay-in-days":5196,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1993,6]]},"abstract":"<jats:p>The receptor binding profile of levomepromazine (LMP) in human brain was compared with that of clozapine (CLOZ) and chlorpromazine (CPZ). LMP showed significantly greater binding affinity for both \u03b1\u20101 and serotonin\u20102 binding sites than either CLOZ or CPZ, and significantly greater binding to \u03b1\u20102 sites than CPZ. A potent pharmacological effect at these receptor sites may explain the beneficial effect of LMP on psychotic symptoms and akathisia in treatment\u2010resistant schizophrenia recently described in 2 open studies. LMP requires further appraisal as a potentially useful neuroleptic in the management of treatment\u2010resistant schizophrenia.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1993.tb03391.x","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T12:43:48Z","timestamp":1187873028000},"page":"380-383","source":"Crossref","is-referenced-by-count":35,"title":["Levomepromazine receptor binding profile in human brain\u2014implications for treatment\u2014resistant schizophrenia"],"prefix":"10.1111","volume":"87","author":[{"given":"N. P. V.","family":"Nair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cecyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Quirion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,23]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"2011","article-title":"Activit\u00e9 d'une nouvelle ph\u00e9nothiazine en psychiatrie et en neurologie","volume":"1956","author":"Sigwald J.","year":"1956","journal-title":"Propri\u00e9t\u00e9s th\u00e9rapeutiques du maleate acide de levomethoxy-3 (dimethylamino-3\u2032 methyl-2\u2032-propyl) 10 phenothiazine (7044 RP). Presse Med"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1192\/bjp.104.436.855","article-title":"Assessing a new phenothiazine","volume":"104","author":"Baker AA.","year":"1958","journal-title":"J Ment Sci"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1192\/bjp.106.442.160","article-title":"A comparative controlled trial of methotrimeprazine (veractil) in chronic schizophrenia","volume":"106","author":"Quinn PJG.","year":"1960","journal-title":"J Ment Sci"},{"key":"e_1_2_1_5_2","volume-title":"Treatment of Psychiatric Disorders. American Psychiatric Association Task Force on Treatments in Psychiatric Disorders","year":"1989"},{"key":"e_1_2_1_6_2","first-page":"777","volume-title":"Comprehensive textbook of psychiatry V","author":"Kane JM.","year":"1985"},{"key":"e_1_2_1_7_2","first-page":"331","article-title":"Neuroleptic affinities for human brain receptors and their use in predicting adverse effects","volume":"45","author":"Richelson E.","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_8_2","first-page":"238","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D\u20101, D\u20102 and serotonin2 pKi values","volume":"251","author":"Meltzer HY.","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt196674436"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1992.tb08603.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199202001-00707"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-70140-5_2"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800330013001"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1094312"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890010508"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(86)90142-9"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1992.tb09752.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(85)91590-2"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/17.2.263"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/17.2.289"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432672"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90793-4"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(88)90519-X"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810140061009"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00428197"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/350610a0"},{"key":"e_1_2_1_28_2","first-page":"158","article-title":"Dopamine receptor genes: new tools for molecular psychiatry","volume":"17","author":"Niznik HB.","year":"1992","journal-title":"J Psychiatry Neurosci"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(92)90076-Q"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.2739\/kurumemedj.37.185"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1993.tb03391.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1993.tb03391.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T20:26:55Z","timestamp":1698265615000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1993.tb03391.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1993,6]]}},"alternative-id":["10.1111\/j.1600-0447.1993.tb03391.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1993.tb03391.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,6]]}}}